默沙东回应停供HPV疫苗:系阶段性调整发货节奏,中国依然是核心市场

界面
05 Feb

2月4日,默沙东宣布将暂停向中国市场供应HPV宫颈癌疫苗(商品名:佳达修),此次供应暂停将至少持续至2025年年中。对于前述事件,2月5日,默沙东在回复界面新闻时表示,暂停供应主要受整体市场环境、消费者需求疲软及渠道库存高等因素影响;默沙东与本土合作伙伴智飞生物进行了沟通,决定自2025年2月起根据消费者需求的动态变化,阶段性调整中国市场的发货节奏,预计将于年中逐步恢复常态。默沙东还称,这一举措将...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10